Connecting Sign in

Insider trades appear within seconds, the rest within the hour.

Get alerts

← Feed

TBPHPharmaceutical Preparations

Theravance Biopharma, Inc.

Alert me on TBPH
0
Insider buys, 6 months
0
Congress trades, 6 months
0
Signals, 6 months

After each filing

8
Sep 18 Sale Farnum Rhonda Insider
1 week
+0.1%S&P +1.3%
1 month
+0.1%S&P +0.6%
3 months
Result in38 trading days
6 months
Result in101 trading days
Jul 2 Sale Samaha Eli Insider
1 week
0.0%S&P +1.4%
1 month
−0.4%S&P +1.7%
3 months
+0.6%S&P +2.8%
6 months
Result in47 trading days
Jun 18 Sale Farnum Rhonda Insider
1 week
+6.3%S&P −2.4%
1 month
+1.6%S&P +0.2%
3 months
+2.7%S&P +2.3%
6 months
Result in38 trading days
Mar 19 Sale Farnum Rhonda Insider
1 week
+8.4%S&P −2.0%
1 month
+19.3%S&P +7.7%
3 months
+18.3%S&P +13.8%
6 months
+21.5%S&P +16.3%
Dec 6, 2025 Sale Farnum Rhonda Insider
1 week
−1.9%S&P −0.4%
1 month
+5.0%S&P +1.2%
3 months
−23.8%S&P −0.8%
6 months
−9.7%S&P +6.7%
Show all 8
Dec 2, 2025 Sale BROSHY ERAN Insider
1 week
−3.4%S&P +0.2%
1 month
−1.5%S&P +0.5%
3 months
−26.3%S&P +0.3%
6 months
−11.2%S&P +11.7%
Nov 14, 2025 Sale BROSHY ERAN Insider
1 week
+6.3%S&P −1.9%
1 month
+0.8%S&P +1.0%
3 months
+10.2%S&P +2.4%
6 months
−6.6%S&P +9.8%
Apr 23, 2025 Sale Rep. George Whitesides House
1 week
+8.9%S&P +2.2%
1 month
−2.5%S&P +5.9%
3 months
+15.6%S&P +16.9%
6 months
+48.2%S&P +23.6%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for TBPH

61 held · newest 561 held · newest 2
Loading the filings.
See all 61 filings for TBPH

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal
No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters
No lobbying reports on file.